WO2005018693A1 - コンタクトレンズ用液剤 - Google Patents
コンタクトレンズ用液剤 Download PDFInfo
- Publication number
- WO2005018693A1 WO2005018693A1 PCT/JP2004/007923 JP2004007923W WO2005018693A1 WO 2005018693 A1 WO2005018693 A1 WO 2005018693A1 JP 2004007923 W JP2004007923 W JP 2004007923W WO 2005018693 A1 WO2005018693 A1 WO 2005018693A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- contact lens
- component
- solution according
- lens solution
- contained
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/12—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/141—Biguanides, e.g. chlorhexidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/143—Quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/265—Carboxylic acids or salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/32—Organic compounds containing nitrogen
- C11D7/3218—Alkanolamines or alkanolimines
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/32—Organic compounds containing nitrogen
- C11D7/3245—Aminoacids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S134/00—Cleaning and liquid contact with solids
- Y10S134/901—Contact lens
Definitions
- the present invention relates to a contact lens solution, and in particular, when disinfecting, cleaning, and storing a contact lens, the contact lens sterilization solution, the contact lens sterilization cleaning solution, the contact lens sterilization storage solution,
- the present invention relates to a liquid that can be advantageously used as a sterilizing and washing preservative solution for lenses.
- contact lenses are classified into non-hydrous contact lenses and hydrous contact lenses according to their materials, hard contact lenses and soft contact lenses, and They are classified into non-ionic contact lenses and ionic contact lenses. If any of these contact lenses is used continuously, microorganisms such as bacteria attached to the lens surface may proliferate while the contact lens is removed from the eye and stored. In general, it is necessary to disinfect contact lenses before wearing them. Especially in soft contact lenses, microorganisms such as bacteria are easy to propagate. Therefore, disinfection before wearing is extremely important.
- Patent Document 1 Japanese Patent Application Laid-Open No. 10-108899
- Patent Document 2 proposes a nonionic tonicity agent together with a predetermined polyquaternium.
- solutions for contact lenses containing Z or amino acids have been proposed.
- JP 2001-242428 A Patent Document 3
- JP 2002-136578 A Patent Document 4
- an amino acid salt specifically, a sodium salt of an amino acid.
- the liquid component is deposited on the contact lens in this manner, the field of view of the lens is deteriorated, the optical characteristics of the lens are adversely affected, and eye irritation is caused by precipitates such as crystals and powders. And problems such as contamination of the lens easily occur. For this reason, even in the contact lens solution proposed by the present inventors, further improvement is desired from the viewpoint of preventing precipitation of the solution component.
- Patent Document 1 Japanese Patent Laid-Open No. 10-108899
- Patent Document 2 Japanese Patent Laid-Open No. 11-249087
- Patent Document 6 Japanese Patent Laid-Open No. 10-137327
- Patent Document 7 Japanese Patent Laid-Open No. 11-52308
- Patent Document 9 JP-A-57-132115
- the present invention has been made in the background of vigorous circumstances, and the problem to be solved is that while securing an excellent bactericidal effect and safety to the eye, It is an object of the present invention to provide a contact lens solution that prevents size change and advantageously suppresses the generation of precipitates in the lens.
- the present invention has been completed on the basis of strong knowledge, and the first aspect thereof is a group consisting of a biguanide fungicide and a quaternary ammonium salt fungicide.
- A selected from the group consisting of glycolic acid and / or aspartic acid
- B 2-amino-2-methyl-1,3-propanediol or a salt thereof
- the B component and the C component are both contained in a molar ratio of 1: 20-1.3: 1.
- the component B is contained so as to have a concentration of 0.01-5 w / w%.
- a neutral amino acid force is further contained.
- the neutral amino acid is 0.1 to 4w.
- glycine is employed as the neutral amino acid.
- propylene glycol power is further contained.
- the propylene glycol power is contained so as to have a concentration of 0.1 1 lw / w%.
- at least one of a surfactant and a Kirei M glaze is further contained.
- a soft contact lens is employed as the target contact lens.
- the bactericidal effect of the bactericide is advantageously expressed and an excellent bactericidal effect is obtained.
- the B component and the C component combine to advantageously suppress the change in the size of the contact lens, and it is possible to effectively prevent the occurrence of deposits derived from the liquid agent on the surface of the lens. It ’s like that.
- the component A exists in an aqueous medium in the form of a cation, and adheres to or adsorbs to a contact lens (particularly, an ionic contact lens having a negative charge). It is easy, but since the B component that is ionized in an aqueous medium to produce an organic anion is added, the adsorption of the A component to the contact lens is suppressed, and the safety for the eye is advantageously enhanced. It is. However, the organic anion (component B) also has an effect on the cation (component A), and the sterilizing effect of the component A tends to be inhibited.
- the content of the bactericide is made extremely small.
- the desired bactericidal efficacy can be advantageously realized, and the safety for the eye is remarkably excellent.
- the B component which is an essential component, is contained so as to have a predetermined concentration.
- the lipophilicity of the contact lens solution is increased, the occurrence of eye irritation is further advantageously suppressed, and an even better feeling of use is obtained.
- the cost of the liquid agent can be reduced.
- the soft contact lens force is treated with the contact lens solution according to the present invention.
- the effects of the present invention as described above can be advantageously exhibited even for soft contact lenses.
- the liquid agent for contact lenses according to the present invention is contained in an aqueous medium mainly composed of water.
- aqueous medium mainly composed of water.
- fungicide or preservative component A
- component B glycolic acid and / or aspartic acid
- AMPD 2-amino-2-methyl-1,3-propanediol
- component C The salt (component C) and force are combined in a predetermined molar ratio, and are contained by being contained.
- the above-mentioned predetermined bactericidal agent (component A) has excellent bactericidal ability, has excellent compatibility with contact lenses, eyes, etc., and is unlikely to be a factor of allergies and other disorders.
- component A the various conventionally known biguanide fungicides and quaternary ammonium salt fungicides that are desired, at least one or a combination of two or more will be used.
- biguanide fungicides are superior to quaternary ammonium salt fungicides even in small amounts that are less susceptible to sterilization by other liquid ingredients (for example, B ingredient). Since it can be realized, it is used more advantageously.
- the biguanide bactericides include, for example, polyhexamethylene biguanide (PHMB), biguanide polymers represented by the following structural formula (I), and the like. .
- PHMB polyhexamethylene biguanide
- I structural formula
- examples of the quaternary ammonium salt fungicide include tetraalkyl ammonium salts such as alkyltrimethyl ammonium chloride and trialkylbenzil ammonium monoxide such as octadecyldimethylbenzyl ammonium chloride.
- Alkyl ammonium salts such as humic salts; alkyl hydroxyalkyl imidazoline quaternary salts represented by hydroxyethyl alkyl imidazoline mouth lides; alkyl isoquinolinum represented by alkyl isoquinolinum bromides Salts; Alkylpyridinium salts; In addition to cationic surfactants such as amidoamines, quaternary ammonium polymers represented by the following structural formulas ( ⁇ )-(IV) and Patent No.
- X— is a monovalent anion such as C1—
- c is an integer of 1 or more
- X— is a monovalent anion such as C1
- R 9 and R 10 are each independently represented by C n H m O p .
- d is an integer of 1 or more
- X— is a monovalent anion such as C1—
- R 14 and R 15 are each independently represented by C n H m O p
- the content of the component A as described above is not particularly limited. Usually, a sufficient sterilizing effect or antiseptic effect can be obtained by using it within a range of about 0.1 lOOOOppm. In the present invention, however, a low concentration, specifically, a concentration in the range of 0.1 to 500 ppm, more preferably 0.1 to 200 ppm, can be advantageously employed in the above concentration range. Thus, in the present invention, an effective sterilizing effect can be obtained even at an extremely low concentration. When the content of the component A is smaller than the above concentration range, a sufficient bactericidal effect (preservative effect) cannot be obtained.
- the liquid agent for contact lenses according to the present invention contains either one or both of glycolic acid and aspartic acid as the B component.
- glycolic acid is more preferably used because it does not lower the bactericidal efficacy of the component A compared to aspartic acid.
- this B component is ionized to form an organic anion, and thus, the A component present as a cation in the aqueous medium is applied to the contact lens. Adsorption is extremely effectively suppressed. This advantageously prevents the occurrence of eye disorders such as inflammation and corneal staining (the corneal staining test with fluorescein stains the entire surface of the cornea), thus ensuring a high degree of eye safety. It becomes like this.
- glycolic acid and Z or aspartic acid are particularly used as the B component among the acidic compounds that generate organic anions
- AM PD or its salts are adopted, so that the sterilizing effect of component A (bactericidal agent) is effectively expressed and the concentration is low.
- component A bactericidal agent
- contact lens size change is prevented, resulting in excellent lens compatibility.
- a specific B component and a specific C component are combined and used at a predetermined ratio, even if the contact lens is treated with such a contact lens solution, the force is applied to the lens. The occurrence of precipitates is effectively prevented.
- the contact lens solution according to the present invention conventionally, as an isotonic agent, it is desirable to use sodium chloride, which is used to adjust the osmotic pressure, and even if sodium chloride is added, the concentration is 0 It is necessary to keep it at 2 w / w% or less, preferably 0. lw / w% or less. That is, the content of sodium chloride is preferably 0-0.2 wZw%, preferably 0-0. Lw / w%. However, if the content power of the sodium chloride exceeds 0.2 w / w%, the bactericidal efficacy of the component A is extremely lowered and the desired bactericidal efficacy cannot be obtained.
- the osmotic pressure of the contact lens solution is generally substantially equal to the physiological osmotic pressure, and is in the range of about 250-400 mOsmZkg.
- concentrations of the constituent components of the liquid agent are appropriately set.
- the contact lens solution according to the present invention may further include other tonicity agents, specifically, if necessary.
- Neutral amino acids (component D) and nonionic tonicity agents (component E) can also be added and incorporated, and contact lenses can be added by further adding such isotonic agents.
- the precipitation of crystals and powders in the water is further effectively suppressed, and the bactericidal effect of the component A is more effectively realized.
- the amount used is within the quantitative range in which the osmotic pressure of the solution does not exceed the desired value. .
- examples of the neutral amino acid described above include glycine, alanine, taurine, ⁇ -aminocaproic acid, and the like.
- One of these neutral amino acids can be used alone. Or two or more types can be used in combination.
- the generation of precipitates in the contact lens is further effectively suppressed, the bactericidal action is assisted, and the lens compatibility is improved. It is more preferably adopted because it is improved.
- the amount used is preferably 0.1 to 4 wZw%. This is because when the amount added is less than 0.1 lwZw%, it is difficult to obtain the effect of addition (isotonic effect), and when the added amount exceeds the neutral amino acid strength wZw%. This is because there is a possibility that crystals or powders may be deposited on the contact lens.
- the nonionic tonicity agent include propylene glycol, glycerin, saccharides, etc., and one of these nonionic tonicity agents can be used alone or Or two or more can be used in combination. Among these, especially in the case of propylene glycol, it is possible to more effectively suppress the generation of precipitates in the contact lens, and increase the viscosity of the liquid agent, thereby advantageously reducing the occurrence of eye irritation. More preferably employed.
- the amount used is preferably 0.1-1 w / w%. However, if the amount used is less than 0.1 lw / w%, it is difficult to obtain an isotonic effect or a reduction effect on eye irritation by a nonionic tonicity agent, and lw / w If added in excess of%, the lens compatibility may be adversely affected.
- a surfactant e.g., sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfite, sodium metabisulfit
- a surfactant as a cleaning agent to the liquid for contact lenses according to the present invention in order to advantageously exhibit the effect of removing dirt such as eye grease (cleaning effect).
- surfactants include, for example, polyglycerol fatty acid ester, polyoxyethylene alkyl etherol, polyoxyethylene 'polyoxypropylene block copolymer, polyoxyethylene polyoxy Propylene ethylenediamine, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene alkyl phenyl ether formaldehyde condensate, polyoxyethylene hydrogenated castor oil, polyoxyethylene alkyl phenyl ether, polyoxyethylene glycerin fatty acid ester, polyoxy Ethylene sorbite fatty acid ester, polyoxyethylene castor oil, polyoxyethylene Sterol, polyoxyethylene hydrogenated sterol, polyoxyethylene fatty acid ester, polyoxyethylene 'polyoxypropylene alkyl ether, polyoxyethylene lanolin alcohol, polyoxyethylene alkylamine, polyoxyethylene alkynolamide, polyoxyethylene alkyl ether Phosphoric acid, polysorbate, etc. can be mentioned, and
- the powerful surfactant is generally about 0.001-5 w / w%, preferably 0.005-
- a chelating agent in order to prevent metal ions such as calcium in tears from adsorbing to contact lenses (particularly soft contact lenses), it is desirable to contain a chelating agent.
- chelating agents include ethylenediamine amine acetic acid (EDTA) and salts thereof, such as ethylenediamine amine acetate 2 sodium (EDTA '2Na), ethylenediamine amine acetate 3 sodium (EDTA' 3Na), and the like.
- EDTA ethylenediamine amine acetic acid
- salts thereof such as ethylenediamine amine acetate 2 sodium (EDTA '2Na), ethylenediamine amine acetate 3 sodium (EDTA' 3Na), and the like.
- a concentration of about 0.01-0. 5 w / w% is used as the addition amount of the chelating agent.
- sodium hydroxide or hydrochloric acid can be cited as a pH adjuster.
- sodium ions and salt ions are generated in aqueous media, so the amount used must be kept as low as possible, and the addition of strong alkalis and strong acids is also necessary. If the ions that make up the strong electrolyte inorganic salt such as sodium chloride are contained in the liquid due to the cocoon, the sodium chloride formed in this way should be mentioned above.
- the concentration of sodium chloride in the solution is 0.2 w / w% In the following, it is desirable that the content is 0.1 lw / w% or less.
- a buffering agent for keeping the pH of the contact lens solution in the above-mentioned range and in a safe range for the eye it is appropriately selected from various conventionally known buffering agents. Will be used. Specifically, citrate buffer, phosphate buffer, borate buffer, carbonate buffer, tris (hydroxymethyl) aminomethane (TRIS) buffer, and even bis (2-hydroxyethyl) ) Good-Buffer, such as iminotris (hydroxymethyl) methane (Bis-Tris), can be exemplified, especially because it is safe for the eyes and can reduce the impact on the contact lens. I can do it. It should be noted that the amount of buffering agent added is generally about 0.01-2 w / w%.
- the contact lens solution according to the present invention obtained as described above includes, for example, a contact lens sterilization solution (disinfectant), a contact lens sterilization cleaning solution, a contact lens sterilization preservation solution, and an outer contour lens.
- a sterilization washing preservation solution for use, etc. it will be suitably used.
- the contact lens solution according to the present invention can be used as an eye drop since excellent safety can be secured for the eye.
- the contact lens is cared for using the contact lens solution according to the present invention, for example, first, the contact lens removed from the eye is filled with the contact lens solution according to the present invention. Disinfection is performed by immersing in a clean container for a predetermined time.
- glycolic acid or aspartic acid was used as the B component, while AMPD was used as the C component.
- glycine was used as the neutral amino acid (component D)
- propylene glycol was used as the nonionic tonicity agent (component E).
- HCO-60 manufactured by Nippon Surfactant Co., Ltd .: polyoxyethylene (60) hydrogenated castor oil
- EDTA '2Na was used as the chelating agent.
- a compound having a structure or property similar to that of the B component and the C component, and sodium chloride were used, respectively.
- lactic acid, gnoleconic acid and citrate are prepared.
- 2-amino-2-methyl-1-propanol (AMP) and arginine are prepared. .
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK04745633T DK1656955T3 (da) | 2003-08-20 | 2004-06-07 | Flydende sammensætning til en kontaktlinse |
DE602004008651T DE602004008651T2 (de) | 2003-08-20 | 2004-06-07 | Flüssige zubereitung für kontaktlinsen |
JP2005513242A JP3894945B2 (ja) | 2003-08-20 | 2004-06-07 | コンタクトレンズ用液剤 |
EP04745633A EP1656955B1 (en) | 2003-08-20 | 2004-06-07 | Liquid preparation for contact lens |
SI200430497T SI1656955T1 (sl) | 2003-08-20 | 2004-06-07 | Tekoci pripravek za kontaktne lece |
PL04745633T PL1656955T3 (pl) | 2003-08-20 | 2004-06-07 | Kompozycja płynna do soczewki kontaktowej |
US11/334,080 US7199089B2 (en) | 2003-08-20 | 2006-01-18 | Liquid preparation for contact lens comprising a disinfectant and buffer mixture |
HK06110448A HK1090855A1 (en) | 2003-08-20 | 2006-09-20 | Liquid preparation for contact lens |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003295863 | 2003-08-20 | ||
JP2003-295863 | 2003-08-20 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/334,080 Continuation US7199089B2 (en) | 2003-08-20 | 2006-01-18 | Liquid preparation for contact lens comprising a disinfectant and buffer mixture |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005018693A1 true WO2005018693A1 (ja) | 2005-03-03 |
Family
ID=34213571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/007923 WO2005018693A1 (ja) | 2003-08-20 | 2004-06-07 | コンタクトレンズ用液剤 |
Country Status (13)
Country | Link |
---|---|
US (1) | US7199089B2 (ja) |
EP (1) | EP1656955B1 (ja) |
JP (1) | JP3894945B2 (ja) |
CN (1) | CN100457194C (ja) |
AT (1) | ATE371464T1 (ja) |
CY (1) | CY1107020T1 (ja) |
DE (1) | DE602004008651T2 (ja) |
DK (1) | DK1656955T3 (ja) |
ES (1) | ES2293298T3 (ja) |
HK (1) | HK1090855A1 (ja) |
PL (1) | PL1656955T3 (ja) |
PT (1) | PT1656955E (ja) |
WO (1) | WO2005018693A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007000518A (ja) * | 2005-06-27 | 2007-01-11 | Tomey Corp | コンタクトレンズ用液剤 |
WO2008041439A1 (fr) * | 2006-09-29 | 2008-04-10 | Menicon Co., Ltd. | Préparation liquide pour lentilles de contact |
JP2009520219A (ja) | 2005-12-14 | 2009-05-21 | ボーシュ アンド ローム インコーポレイティド | レンズを包装する方法 |
JP5296953B1 (ja) * | 2012-12-12 | 2013-09-25 | 株式会社メニコン | 非イオン性ソフトコンタクトレンズ用消毒液 |
JPWO2017094508A1 (ja) * | 2015-11-30 | 2018-08-23 | ロート製薬株式会社 | 眼科組成物 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8138156B2 (en) * | 2006-10-18 | 2012-03-20 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
US20080214421A1 (en) * | 2007-02-19 | 2008-09-04 | Fang Zhao | Contact lens care composition |
US8629099B2 (en) * | 2008-03-25 | 2014-01-14 | Bausch & Lomb Incorporated | Ophthalmic compositions comprising a dipeptide |
US8431751B1 (en) | 2008-12-24 | 2013-04-30 | Alcon Research, Ltd. | Polymeric quaternary ammonium compounds with vicinal hydroxy groups |
EP2642333B1 (en) * | 2010-11-17 | 2020-08-26 | Menicon Co., Ltd. | Soft contact lens application method |
US8324171B1 (en) | 2012-02-06 | 2012-12-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
US8664180B2 (en) | 2012-02-06 | 2014-03-04 | Bausch & Lomb Incorporated | Ophthalmic compositions containing diglycine |
JP6106516B2 (ja) * | 2013-05-08 | 2017-04-05 | 株式会社シード | アカントアメーバ角膜炎の予防剤及び治療剤 |
WO2017142005A1 (ja) * | 2016-02-17 | 2017-08-24 | 株式会社シード | 抗アカントアメーバコンタクトレンズ用溶剤 |
CN109381480B (zh) * | 2018-11-15 | 2021-02-09 | 江苏聚锦生物医疗科技有限责任公司 | 复配聚六亚甲基双胍消毒液及其制备方法 |
CN113088411A (zh) * | 2021-04-08 | 2021-07-09 | 山西利普达医药科技有限公司 | 一种含聚季铵盐-1的眼用清洗灭活病毒组合物及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10137327A (ja) * | 1996-11-13 | 1998-05-26 | Tomey Technol Corp | コンタクトレンズ用汚れ付着防止組成物及びそれを用いたコンタクトレンズの汚れ付着防止方法 |
JP2001242428A (ja) * | 1999-12-20 | 2001-09-07 | Tomey Corp | コンタクトレンズ用液剤およびソフトコンタクトレンズの洗浄、消毒、保存方法 |
JP2002136578A (ja) * | 2000-11-01 | 2002-05-14 | Tomey Corp | ソフトコンタクトレンズ用液剤およびソフトコンタクトレンズの洗浄、消毒、保存方法 |
JP2003116972A (ja) * | 2001-10-10 | 2003-04-22 | Tomey Corp | 眼科用液剤およびそれを用いた眼用製品の洗浄、消毒、保存方法 |
JP2003160482A (ja) * | 2001-09-17 | 2003-06-03 | Menicon Co Ltd | 眼科用液剤及びコンタクトレンズ用液剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2090013B (en) | 1980-12-18 | 1984-04-11 | Smith & Nephew Ass | Soft contact lens sterilising solution |
DE3169105D1 (en) | 1980-12-18 | 1985-03-28 | Smith & Nephew Ass | Lens sterilising solutions and their use |
JP3142245B2 (ja) * | 1996-06-28 | 2001-03-07 | 株式会社資生堂 | 皮膚外用剤 |
JP3698832B2 (ja) | 1996-10-08 | 2005-09-21 | 株式会社メニコン | コンタクトレンズ用液剤 |
DE69725434T3 (de) | 1996-11-13 | 2010-07-15 | Menicon Co., Ltd., Nagoya | Zusammensetzung zur behandlung von kontaktlinsen und methode zur anwendung derselben |
JP3745508B2 (ja) | 1997-08-04 | 2006-02-15 | 株式会社トーメー | コンタクトレンズ用液体洗浄組成物及び洗浄方法 |
ATE218887T1 (de) | 1996-12-13 | 2002-06-15 | Alcon Lab Inc | Verwendung von niedermolekularen aminoalkoholen in ophthalmologischen präparaten |
US5858346A (en) * | 1997-05-09 | 1999-01-12 | Allergan | Compositions and methods for enhancing contact lens wearability |
JPH11249087A (ja) | 1997-12-18 | 1999-09-17 | Tome:Kk | コンタクトレンズ用液剤 |
EP1050304A1 (en) * | 1998-11-16 | 2000-11-08 | Rohto Pharmaceutical Co., Ltd. | Liquid ophthalmic preparations |
US7678836B2 (en) * | 1999-11-04 | 2010-03-16 | Fxs Ventures, Llc | Method for rendering a contact lens wettable |
US20040185028A1 (en) * | 2003-03-19 | 2004-09-23 | Zhenze Hu | Antimicrobial compositions containing ethanolamine buffer and biguanide disinfectant |
-
2004
- 2004-06-07 ES ES04745633T patent/ES2293298T3/es active Active
- 2004-06-07 EP EP04745633A patent/EP1656955B1/en active Active
- 2004-06-07 PT PT04745633T patent/PT1656955E/pt unknown
- 2004-06-07 DE DE602004008651T patent/DE602004008651T2/de active Active
- 2004-06-07 JP JP2005513242A patent/JP3894945B2/ja active Active
- 2004-06-07 PL PL04745633T patent/PL1656955T3/pl unknown
- 2004-06-07 DK DK04745633T patent/DK1656955T3/da active
- 2004-06-07 WO PCT/JP2004/007923 patent/WO2005018693A1/ja active IP Right Grant
- 2004-06-07 CN CNB2004800236502A patent/CN100457194C/zh active Active
- 2004-06-07 AT AT04745633T patent/ATE371464T1/de active
-
2006
- 2006-01-18 US US11/334,080 patent/US7199089B2/en active Active
- 2006-09-20 HK HK06110448A patent/HK1090855A1/xx not_active IP Right Cessation
-
2007
- 2007-11-23 CY CY20071101501T patent/CY1107020T1/el unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10137327A (ja) * | 1996-11-13 | 1998-05-26 | Tomey Technol Corp | コンタクトレンズ用汚れ付着防止組成物及びそれを用いたコンタクトレンズの汚れ付着防止方法 |
JP2001242428A (ja) * | 1999-12-20 | 2001-09-07 | Tomey Corp | コンタクトレンズ用液剤およびソフトコンタクトレンズの洗浄、消毒、保存方法 |
JP2002136578A (ja) * | 2000-11-01 | 2002-05-14 | Tomey Corp | ソフトコンタクトレンズ用液剤およびソフトコンタクトレンズの洗浄、消毒、保存方法 |
JP2003160482A (ja) * | 2001-09-17 | 2003-06-03 | Menicon Co Ltd | 眼科用液剤及びコンタクトレンズ用液剤 |
JP2003116972A (ja) * | 2001-10-10 | 2003-04-22 | Tomey Corp | 眼科用液剤およびそれを用いた眼用製品の洗浄、消毒、保存方法 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007000518A (ja) * | 2005-06-27 | 2007-01-11 | Tomey Corp | コンタクトレンズ用液剤 |
JP2009520219A (ja) | 2005-12-14 | 2009-05-21 | ボーシュ アンド ローム インコーポレイティド | レンズを包装する方法 |
WO2008041439A1 (fr) * | 2006-09-29 | 2008-04-10 | Menicon Co., Ltd. | Préparation liquide pour lentilles de contact |
JPWO2008041439A1 (ja) * | 2006-09-29 | 2010-02-04 | 株式会社メニコン | コンタクトレンズ用液剤 |
JP5296953B1 (ja) * | 2012-12-12 | 2013-09-25 | 株式会社メニコン | 非イオン性ソフトコンタクトレンズ用消毒液 |
JPWO2017094508A1 (ja) * | 2015-11-30 | 2018-08-23 | ロート製薬株式会社 | 眼科組成物 |
Also Published As
Publication number | Publication date |
---|---|
EP1656955A1 (en) | 2006-05-17 |
PL1656955T3 (pl) | 2008-01-31 |
ATE371464T1 (de) | 2007-09-15 |
CN1835771A (zh) | 2006-09-20 |
DK1656955T3 (da) | 2007-12-27 |
JPWO2005018693A1 (ja) | 2007-10-04 |
HK1090855A1 (en) | 2007-01-05 |
US20060122080A1 (en) | 2006-06-08 |
US7199089B2 (en) | 2007-04-03 |
CY1107020T1 (el) | 2012-09-26 |
PT1656955E (pt) | 2007-12-10 |
DE602004008651T2 (de) | 2008-06-05 |
JP3894945B2 (ja) | 2007-03-22 |
EP1656955A4 (en) | 2006-11-02 |
ES2293298T3 (es) | 2008-03-16 |
DE602004008651D1 (de) | 2007-10-11 |
EP1656955B1 (en) | 2007-08-29 |
CN100457194C (zh) | 2009-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3883739B2 (ja) | コンタクトレンズ用殺菌液 | |
US7199089B2 (en) | Liquid preparation for contact lens comprising a disinfectant and buffer mixture | |
JP2554237B2 (ja) | コンタクトレンズの消毒保存用溶液 | |
JP4255656B2 (ja) | 眼科用液剤及びコンタクトレンズ用液剤 | |
JP2008510568A (ja) | トリアルカノールアミン・アルコキシレートバッファー剤を含む組成物 | |
JP4295939B2 (ja) | コンタクトレンズ用液剤 | |
AU2002233204A1 (en) | Aqueous disinfecting systems | |
JP2008510809A (ja) | N,n,n’,n’−テトラキス(ヒドロキシアルキル)ジアミンバッファー剤、又はn,n,n’,n’−テトラキス(ヒドロキシアルコキシ)ジアミンバッファー剤を含む組成物 | |
JP5296953B1 (ja) | 非イオン性ソフトコンタクトレンズ用消毒液 | |
US6417144B2 (en) | Solution for contact lenses | |
WO2004084877A1 (ja) | 眼科用組成物 | |
WO2009096038A1 (ja) | コンタクトレンズ用液剤 | |
WO2003026420A1 (fr) | Solutions bactericides | |
WO2008041439A1 (fr) | Préparation liquide pour lentilles de contact | |
JP2001242428A (ja) | コンタクトレンズ用液剤およびソフトコンタクトレンズの洗浄、消毒、保存方法 | |
JPH11322515A (ja) | コンタクトレンズ用液剤 | |
JP4947895B2 (ja) | コンタクトレンズケア用組成物 | |
WO2014091575A1 (ja) | イオン性ソフトコンタクトレンズ用消毒液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480023650.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005513242 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11334080 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004745633 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004745633 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11334080 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2004745633 Country of ref document: EP |